FDA allows the use of Babesia test under an Investigational New Drug (IND) study for selected US blood banks
by Press Release from Outbreak News Today on (#2NXMB)
Global healthcare company, Grifols, announced today that the U.S. Food and Drug Administration (FDA) has allowed collection and testing of blood samples for screening with Procleix Babesia assay under an Investigational New Drug (IND) study. Babesia is caused by microscopic parasites and is transmitted primarily through tick bites. However, as the disease is spread during ticks' young ["]
The post FDA allows the use of Babesia test under an Investigational New Drug (IND) study for selected US blood banks appeared first on Outbreak News Today.